Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

[Knowledge, attitudes and practices of women of childbearing age with regards to cervical cancer preventive measures in the MIFI health district, Cameroon].

Dakenyo RD, Kenfack B, Vogue N, Tsakoue EF, Ebode ME, Cumber SN.

Pan Afr Med J. 2018 Nov 12;31:172. doi: 10.11604/pamj.2018.31.172.16320. eCollection 2018. French.

2.

Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer.

Papathemelis T, Knobloch S, Gerken M, Scharl A, Anapolski M, Ignatov A, Inwald EC, Ortmann O, Scharl S, Klinkhammer-Schalke M.

J Cancer Res Clin Oncol. 2019 May;145(5):1369-1376. doi: 10.1007/s00432-019-02890-7. Epub 2019 Mar 18.

PMID:
30887156
3.

Participation in a Swedish cervical cancer screening program among women with psychiatric diagnoses: a population-based cohort study.

Eriksson EM, Lau M, Jönsson C, Zhang C, Risö Bergerlind LL, Jonasson JM, Strander B.

BMC Public Health. 2019 Mar 18;19(1):313. doi: 10.1186/s12889-019-6626-3.

4.

Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types.

Ryser M, Berlaimont V, Karkada N, Mihalyi A, Rappuoli R, van der Most R.

Expert Rev Vaccines. 2019 Mar;18(3):309-322. doi: 10.1080/14760584.2019.1579647. Epub 2019 Mar 4.

PMID:
30739514
5.

Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.

Nishio S, Mikami Y, Tokunaga H, Yaegashi N, Satoh T, Saito M, Okamoto A, Kasamatsu T, Miyamoto T, Shiozawa T, Yoshioka Y, Mandai M, Kojima A, Takehara K, Kaneki E, Kobayashi H, Kaku T, Ushijima K, Kamura T.

Gynecol Oncol. 2019 Apr;153(1):13-19. doi: 10.1016/j.ygyno.2019.01.022. Epub 2019 Jan 29.

6.

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.

Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ.

Int J Gynaecol Obstet. 2019 Apr;145(1):40-46. doi: 10.1002/ijgo.12773.

PMID:
30702142
7.

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.

Egli-Gany D, Spaar Zographos A, Diebold J, Masserey Spicher V, Frey Tirri B, Heusser R, Dillner J, Petignat P, Sahli R, Low N; CIN3+plus study group.

BMC Cancer. 2019 Jan 30;19(1):111. doi: 10.1186/s12885-018-5248-y.

8.

International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.

Hodgson A, Olkhov-Mitsel E, Howitt BE, Nucci MR, Parra-Herran C.

J Clin Pathol. 2019 May;72(5):347-353. doi: 10.1136/jclinpath-2018-205632. Epub 2019 Jan 24.

PMID:
30679193
9.

Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination.

Nartey Y, Hill P, Amo-Antwi K, Asmah R, Nyarko K, Yarney J, Damale N, Cox B.

Ghana Med J. 2018 Jun;52(2):94-102. doi: 10.4314/gmj.v52i2.6.

10.

Cervical cancer screening in Sweden 2014-2016.

Hortlund M, Elfström KM, Sparén P, Almstedt P, Strander B, Dillner J.

PLoS One. 2018 Dec 17;13(12):e0209003. doi: 10.1371/journal.pone.0209003. eCollection 2018.

11.

Prevalence of high-risk human papilloma virus in liquid-based cervical samples from Turkish women with normal and abnormal cytology.

Seneldir H, Kir G.

Diagn Cytopathol. 2019 Feb;47(2):100-104. doi: 10.1002/dc.24022. Epub 2018 Nov 20.

PMID:
30457213
12.

Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.

Nagase S, Ohta T, Takahashi F, Enomoto T; 2017 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology.

J Obstet Gynaecol Res. 2019 Feb;45(2):289-298. doi: 10.1111/jog.13863. Epub 2018 Nov 13.

PMID:
30426591
13.

New prophylactics human papilloma virus (HPV) vaccines against cervical cancer.

Barra F, Maggiore ULR, Bogani G, Ditto A, Signorelli M, Martinelli F, Chiappa V, Lorusso D, Raspagliesi F, Ferrero S.

J Obstet Gynaecol. 2019 Jan;39(1):1-10. doi: 10.1080/01443615.2018.1493441. Epub 2018 Oct 27. Review.

PMID:
30370796
14.

Pelvic abscess: A late complication of abdominal trachelectomy for cervical cancer.

Okugawa K, Sonoda K, Ohgami T, Yasunaga M, Kaneki E, Yahata H, Kato K.

J Obstet Gynaecol Res. 2019 Feb;45(2):412-416. doi: 10.1111/jog.13814. Epub 2018 Sep 24.

PMID:
30251418
15.

Increased Cancer Screening for Low-income Adults Under the Affordable Care Act Medicaid Expansion.

Hendryx M, Luo J.

Med Care. 2018 Nov;56(11):944-949. doi: 10.1097/MLR.0000000000000984.

PMID:
30199428
16.

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.

Campos NG, Tsu V, Jeronimo J, Regan C, Resch S, Clark A, Sy S, Kim JJ.

Int J Cancer. 2019 Feb 15;144(4):687-696. doi: 10.1002/ijc.31823. Epub 2018 Oct 16.

17.

Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: Results of a prospective cohort study with up to 6.4 years of follow-up from India.

Joshi S, Muwonge R, Kulkarni V, Deodhar K, Mandolkar M, Lucas E, Sankaranarayanan R.

Int J Cancer. 2019 Mar 1;144(5):1082-1091. doi: 10.1002/ijc.31826. Epub 2018 Nov 20.

PMID:
30132840
18.

HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri.

Forslund O, Miriam Elfström K, Lamin H, Dillner J.

Int J Cancer. 2019 Mar 1;144(5):1073-1081. doi: 10.1002/ijc.31819. Epub 2018 Oct 4.

PMID:
30125346
19.

[The prophylactic operational model integrated with occupational healthcare - Prophylactic of some types of cancers among women].

Wiszniewska M, Magnuska J, Lipińska-Ojrzanowska A, Pepłońska B, Hanke W, Kalinka J, Skręt-Magierło J, Zadrożny M, Walusiak-Skorupa J.

Med Pr. 2018 Aug 20;69(4):439-455. doi: 10.13075/mp.5893.00665. Epub 2018 Jul 23. Review. Polish.

20.

Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study.

Thapa N, Maharjan M, Shrestha G, Maharjan N, Petrini MA, Zuo N, He C, Yang J, Xu M, Ge C, Song Z, Cai H.

BMC Infect Dis. 2018 Jul 20;18(1):338. doi: 10.1186/s12879-018-3175-9.

Supplemental Content

Loading ...
Support Center